Zota Health Care Limited (ZOTA.NS)
Zota Health Care Limited operates in the Biotechnology industry of the Healthcare sector, headquartered in Surat, GU, IN. The stock last traded at $1131.30, down 8.86% on the session, giving a market capitalisation of $34.32B. Its beta of 0.34 implies it has historically moved less than the broad market.
Zota Health Care Limited is an Indian pharmaceutical firm dedicated to the development, manufacturing, and distribution of a broad spectrum of health-related products across India. Its extensive portfolio encompasses generic medications, over-the-counter (OTC) remedies, traditional Ayurvedic formulations, and nutritional supplements (nutraceuticals). The company places a particular emphasis on supplying treatments for various long-term illnesses, including but not limited to heart disease, diabetes, and thyroid conditions. By March 31, 2021, Zota had established a considerable retail network, operating 591 stores under its DAVAINDIA brand name throughout 24 states in India. The company was founded in 1995 and is currently headquartered in Surat, India.
Zota Health Care Limited is most often compared with the following Healthcare names: